- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
CD55 Rabbit Monoclonal Antibody 17C68 / DAF Rabbit Monoclonal Antibody targets CD55, a membrane-associated complement regulatory protein also known as decay-accelerating factor (DAF). CD55 protects host cells from complement-mediated damage by accelerating the dissociation of C3 and C5 convertases, thereby limiting amplification of the complement cascade. The protein belongs to the regulators of complement activation family and contains four extracellular complement control protein domains. Its predominant membrane-associated form is attached to the plasma membrane through a glycosylphosphatidylinositol (GPI) anchor, positioning CD55 to regulate complement activity directly at the cell surface. The mature protein is extensively glycosylated, contributing to its higher apparent molecular weight relative to the calculated polypeptide mass.
CD55 regulates complement activation through the classical, lectin, and alternative pathways. In the classical and lectin pathways, it accelerates dissociation of C2a from the C4b2a convertase, while in the alternative pathway it promotes displacement of Bb from C3bBb. These activities shorten convertase lifetimes and reduce downstream complement amplification. Unlike CD59, which inhibits formation of the membrane attack complex, CD55 acts earlier in the complement cascade. Together, these membrane-associated regulatory proteins help preserve cellular integrity while allowing complement-mediated immune defense against appropriate targets. CD55 activity is especially important where circulating complement components encounter host cell membranes.
Abnormal CD55 expression contributes to several complement-associated disorders. In paroxysmal nocturnal hemoglobinuria (PNH), acquired defects in GPI-anchor biosynthesis cause loss of multiple membrane proteins, including CD55 and CD59, from affected blood cells. Their increased susceptibility to complement-mediated injury contributes to the disease. Inherited CD55 deficiency causes CHAPLE disease, characterized by complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy. CD55 also carries antigens of the Cromer blood group system, linking its extracellular structure to clinically relevant erythrocyte surface determinants.
CD55 expression has additionally been investigated in cancer, infection, inflammation, and transplantation. Elevated expression on certain tumor cells may reduce their susceptibility to complement-dependent immune injury, although its biological consequences depend on cellular context. CD55 also interacts with ADGRE5/CD97 and participates in cellular interactions beyond complement regulation. CD55 Rabbit Monoclonal Antibody 17C68 supports investigation of membrane-associated complement regulation, disease-related changes in CD55 expression, and the mechanisms governing cellular resistance to complement-mediated damage.
For a published monoclonal antibody targeting this complement regulatory protein, see our CD55 Antibody clone 143-30.
Optimal dilution of the CD55 Rabbit Monoclonal Antibody 17C68 / DAF Rabbit Monoclonal Antibody should be determined by the researcher.
A synthesized peptide derived from human CD55 protein was used as the immunogen for the CD55 Rabbit Monoclonal Antibody 17C68.
The CD55 Rabbit Monoclonal Antibody 17C68 can be stored at -20oC.
Decay accelerating factor antibody, DAF antibody, complement decay-accelerating factor antibody, complement regulatory protein CD55 antibody, CD55 antigen antibody, CD55 glycoprotein antibody, GPI-anchored CD55 antibody, membrane decay-accelerating factor antibody, complement regulator DAF antibody, Cromer blood group antigen antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.